Succurro E, Vizza P, Papa A, Miceli S, et al. Effects of 26-week treatment with empagliflozin versus glimepiride on myocardial glucose metabolic rate in patients with type 2 diabetes: the randomized, open-label, active-controlled crossover FIORE trial. Diabetes Obes Metab 2022 Jul 15. doi: 10.1111/dom.14816.
PMID: 35837991